COAG

Hemab Therapeutics Holdings, Inc.

$25.74

Mkt Cap $51.7M

52w Low $23.48 17.2% of range 52w High $36.61

50d MA $27.34 200d MA $27.34

P/E (TTM) —

EV/EBITDA —

P/B —

Debt/Equity —

ROE —

P/FCF —

RSI (14) —

ATR (14) —

Beta —

50d MA $27.34

200d MA $27.34

Avg Volume —

CIK (SEC)

2114044

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
May 6, 2026	RA CAPITAL MANAGEMENT, L.P.	—	Buy	53,407	$24.83	$1.3M	6,314,525	+2.92%	—
May 6, 2026	RA CAPITAL MANAGEMENT, L.P.	—	Buy	14,611	$23.77	$347K	6,261,118	+2.92%	—
May 5, 2026	RA CAPITAL MANAGEMENT, L.P.	—	Buy	10,268	$25.00	$257K	6,246,507	+2.92%	—
May 5, 2026	RA CAPITAL MANAGEMENT, L.P.	—	Buy	87,143	$24.59	$2.1M	6,236,239	+2.92%	—
May 4, 2026	RA CAPITAL MANAGEMENT, L.P.	—	Buy	133,750	$18.00	$2.4M	354,938	+2.92%	—
May 4, 2026	RA CAPITAL MANAGEMENT, L.P.	—	Buy	2,541,250	$18.00	$45.7M	6,149,096	+2.92%	—

· Source: massive.com